Skip to main content
Skip to section navigation
Skip to footer
Home
About Us
Our Leadership
Our Science
Introduction to
FcRn
Pipeline & Therapeutic Areas
Patients & Caregivers
Our Commitment
Therapeutic Areas & Clinical Trials
For Investors
Overview
News & Events
Company Info
Financials
Stock Data
SEC Filings
Governance
Join Us
Values & Culture
Explore Careers
Contact Us
All SEC Filings
View Main Content
For Investors
For Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Presentations
Email Alerts
Company Info
Overview
Executive Leadership Team
Contacts
FAQ
Financials
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Whistleblower Policy
Filing Type:
View all
10-K
10-Q
144
25-NSE
3
4
4/A
424B3
424B4
424B5
424B7
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DEFM14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS EX
PRE 14A
PREM14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View all
2024
2023
2022
2021
2020
2019
Date
Form
Description
PDF
XBRL
Pages
05/03/19
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
2
05/03/19
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
expand_more
EX-3.2
EX-5.1
EX-23.1
164
05/01/19
UPLOAD
SEC-generated letter
Documents
expand_more
TEXT-EXTRACT
2
04/29/19
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
expand_more
EX-1.1
EX-3.1
EX-3.2
EX-3.3
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-5.1
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-14
EX-99.1
EX-99.2
EX-99.3
EX-99.4
EX-99.5
EX-99.6
EX-99.7
197
04/16/19
S-1
General form of registration statement for all companies including face-amount certificate companies
Documents
expand_more
EX-23.1
150
02/26/19
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
148
02/25/19
DRSLTR
Correspondence Related to Draft Registration Statement
3
02/11/19
UPLOAD
SEC-generated letter
Documents
expand_more
TEXT-EXTRACT
2
01/23/19
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
148
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
37
Page
38
Page
39
Page
40
Page
41
Page
42
Page
43
Page
44
Page
45
Page
46
Select a page:
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Page 41
Page 42
Page 43
Page 44
Page 45
Page 46
Email Alerts
Contacts
RSS News Feed